Antimicrobial resistance in Shigella flexneri and Shigella sonnei in Hong Kong, 1986 to 1995.

Antimicrobial Agents and Chemotherapy
Y W ChuA F Cheng

Abstract

Three hundred and thirty-three Shigella isolates obtained in 1986 to 1995 were tested for their susceptibilities to 19 antimicrobial agents. Nalidixic acid resistance had emerged in 59.6% of Shigella flexneri isolates during 1994 to 1995, with all tested resistant isolates having the mutation in gyrA encoding the Ser-83 alteration. Multiresistance (resistance to four or more agents) was more common in S. flexneri than in Shigella sonnei.

References

Feb 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C E VoogdB van Klingeren
Nov 1, 1990·The Journal of Infectious Diseases·R V TauxeP A Blake
Apr 1, 1995·Antimicrobial Agents and Chemotherapy·S AshkenaziZ Samra
Oct 1, 1994·Antimicrobial Agents and Chemotherapy·M RahmanJ P Butzler
Nov 1, 1994·Antimicrobial Agents and Chemotherapy·J VilaT Jimenez de Anta
Jun 1, 1993·Epidemiology and Infection·J M LingG L French
Jul 1, 1996·Antimicrobial Agents and Chemotherapy·K Maneewannakul, S B Levy
Jan 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R B SackE H Khan

❮ Previous
Next ❯

Citations

Sep 15, 2007·Journal of Gastroenterology and Hepatology·Farid H Abu ElamreenJamal Elshikh Deeb
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Trung Vu NguyenAndrej Weintraub
Aug 28, 2020·The Journal of Venomous Animals and Toxins Including Tropical Diseases·Ashish K LamiyanNeelima R Kumar
Apr 5, 2000·Journal of Pediatric Gastroenterology and Nutrition·W S Lee
Sep 10, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S D PutnamR W Frenck
Oct 21, 2004·Seminars in Pediatric Infectious Diseases·Shai Ashkenazi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases
M UchimuraK Koiwai
Journal of Applied Microbiology
C F BagamboulaJ Debevere
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
M M NaviaJ Vila
© 2022 Meta ULC. All rights reserved